PerkinElmer, Inc., a global leader focused on the health and safety of people and the environment, today announced the appointment of Achim von Leoprechting, Ph.D., as vice president and general manager, cellular imaging and analysis solutions. In this role, Dr.von Leoprechting will be responsible for driving the cellular imaging business for PerkinElmer.

Dr. von Leoprechting brings broad experience in scientific, operational and sales leadership, a strong customer relationship focus, as well as in-depth knowledge of the market to his new appointment.

“We look forward to Achim taking on his new strategic role in leading our cellular imaging and analysis group, as we continue to drive innovation in research technologies to better human health,” said Richard Eglen, Ph.D., president, Bio-discovery, PerkinElmer. “PerkinElmer is an acknowledged leader in life sciences imaging technologies and software. Achim brings significant global and technical knowledge which will be instrumental in providing customers with the imaging solutions they need to better understand the biological processes of disease.”

“The importance of developing cutting-edge cellular imaging solutions continues to increase as researchers require advanced 3D and 4D imaging, high content screening and data analysis and management tools,” said Dr. von Leoprechting. “PerkinElmer has made a strategic commitment to increasing excellence in cellular science, and we continue to provide new and effective solutions to meet the growing needs of life science research. I am delighted by the opportunity to play a pivotal role in serving the worldwide imaging and analysis community. By enabling new discoveries, we can advance the comprehension of the origins of disease in order to combat them better.”

Prior to his new appointment, Dr. von Leoprechting was the European sales director within the Company’s Bio-discovery business element, where he led growth in instrument and reagent sales. He has been with the Company in a variety of technology, sales and marketing leadership roles since PerkinElmer acquired his previous employer, Packard BioScience in 2002.

Dr. von Leoprechting received his Ph.D. in Biology from Albert-Ludwigs-University, Freiburg, Germany, and has numerous publications in cell biology, including the areas of cancer research, biochemical and cellular assay development and structural protein research.